Fundraising Fox
Deepmedchem
Founded 2023 · 10 employees on LinkedIn · 1 known investors
Find your way into Deepmedchem
Sign up to see every warm intro you have to Deepmedchem
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deepmedchem team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Deep MedChem develops CHEESE, a family of AI products for drug discovery that let researchers search, predict, and explore 2D, 3D shape, electrostatic, and activity similarity across 40T+ molecules, deployable on cloud or on-premises. It serves pharmaceutical and biotech drug discovery teams and is a spin-off from The MAMA AI and i&i Prague connected to the IOCB medicinal chemistry institute in Europe.
Founders & leadership
JM
Jan MacekChief Executive OfficerJan Macek leads Deep MedChem, a spin-off from collaboration between The MAMA AI team (with ex-IBM Watson and IBM Research researchers) and the Institute of Organic Chemistry and Biochemistry in Prague, developing AI and machine learning methods for drug discovery and medicinal chemistry. He also serves as co-founder and co-CEO at The MAMA AI and director of services at TELMA AI.
ML
Miroslav LžičařChief Technical OfficerMiroslav Lžičař is Chief Technical Officer at Deep MedChem, an AI drug discovery platform spin-off from The MAMA AI and IOCB medicinal chemistry institute, where he has developed vector-space molecular search systems and transformer architectures for chemical space exploration. His background spans research engineering roles in machine learning, information retrieval, and scientific AI systems.
JR
Jiří RůžičkaChief Business OfficerJiří Růžička is Chief Business Officer at Deep MedChem, an AI drug discovery platform spin-off from IOCB Prague's medicinal chemistry institute. He leads business development for the company's chemical search and design tools.
Investors · 1
Frequently asked questions
- What does Deepmedchem do?
- Deep MedChem develops CHEESE, a family of AI products for drug discovery that let researchers search, predict, and explore 2D, 3D shape, electrostatic, and activity similarity across 40T+ molecules, deployable on cloud or on-premises. It serves pharmaceutical and biotech drug discovery teams and is a spin-off from The MAMA AI and i&i Prague connected to the IOCB medicinal chemistry institute in Europe.
- Who are Deepmedchem's investors?
- Deepmedchem's investors include Biotech Investments S.R.O.